You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Resistant Hodgkins Lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Lymphoma, Adolescent Behavior, Chemo Effect Trial (Description of therapeutical results)

Not yet recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Description of therapeutical results
  • (no location specified)
Dec 15, 2022

Childhood Non-Hodgkin Lymphoma, Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia Trial in Oslo,

Recruiting
  • Childhood Non-Hodgkin Lymphoma
  • +2 more
  • Goal Management Training (GMT)
  • Brain Health Workshop (BHW)
  • Oslo, Norway
  • +2 more
May 25, 2022

CD20 Positive Non Hodgkin Lymphoma Trial in United States (CPO107)

Recruiting
  • CD20 Positive Non Hodgkin Lymphoma
  • Los Angeles, California
  • +4 more
Aug 9, 2022

Hodgkins Lymphoma, Non Hodgkins Lymphoma Trial in Houston (TAA-specific CTLs)

Recruiting
  • Hodgkins Lymphoma
  • Non Hodgkins Lymphoma
  • TAA-specific CTLs
  • Houston, Texas
    Texas Children's Hospital
Jul 14, 2022

Hairy Cell and Other Leukemias, and to Develop Recombinant

Recruiting
  • Hairy Cell Leukemia (HCL)
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Hodgkin Disease Trial in Houston (ABVE-PC, DECA)

    Active, not recruiting
    • Hodgkin Disease
    • Houston, Texas
      Texas Children's Hospital
    Jan 19, 2022

    Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma Trial in New York (fludarabine, cyclophosphamide, thiotepa, radiation

    Completed
    Has Results
    • Leukemia
    • +4 more
    • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 10, 2022

    Non Hodgkins Lymphoma, Diffuse Large B-cell Lymphoma Trial in Japan (tafasitamab, lenalidomide, parsaclisib)

    Recruiting
    • Non Hodgkins Lymphoma
    • Diffuse Large B-cell Lymphoma
    • Aichi, Japan
    • +4 more
    Jan 24, 2022

    B-cell Non-Hodgkins Lymphoma (B-NHL) Trial (Odronextamab, REGN5837)

    Not yet recruiting
    • B-cell Non-Hodgkins Lymphoma (B-NHL)
    • (no location specified)
    Jan 5, 2023

    Circulating Cell DNA in Pediatric Mature B Cell Non-Hodgkins

    Not yet recruiting
    • Non-hodgkin Lymphoma
    • modified BFM-95 protocol
    • (no location specified)
    Jul 9, 2021

    Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma Trial run by the NCI (Interferon, Rituxan and

    Recruiting
    • Lymphomatoid Granulomatosis
    • +3 more
    • Interferon
    • Rituxan and EPOCH
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Lymphoma, B-Cell, Lymphoma, Non-hodgkins, Chronic Lymphocytic Leukemia Trial run by the NCI (Anti-cluster of differentiation 19

    Terminated
    Has Results
    • Lymphoma, B-Cell
    • +3 more
    • Anti-cluster of differentiation 19 (CD19)-Chimeric Antigen Receptors (CAR) and Anti-cluster of differentiation 20 (CD20)-CAR T cells
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2022

    Lymphoma, Hodgkin's Disease, Relapse Trial in Houston (TGFbeta resistant LMP-specific CTLs)

    Active, not recruiting
    • Lymphoma
    • +3 more
    • TGFbeta resistant LMP-specific CTLs
    • Houston, Texas
    • +1 more
    Dec 8, 2021

    Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Oklahoma City, Houston (Fenretinide,

    Terminated
    • Acute Myelogenous Leukemia
    • +2 more
    • Oklahoma City, Oklahoma
    • +1 more
    Mar 17, 2022

    B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Trial in Aurora (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B-cell Non Hodgkin Lymphoma
    • CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
    • Aurora, Colorado
      Children's Hospital Colorado
    Nov 9, 2022

    Lymphoma, Non-Hodgkin's, Adult Trial in Rosario, Caba (Evaluation of first line treatment in patients with stage I and II LBCL)

    Recruiting
    • Lymphoma, Non-Hodgkin's, Adult
    • Evaluation of first line treatment in patients with stage I and II LBCL
    • Paraná, Entre Ríos, Argentina
    • +6 more
    Dec 29, 2022

    Small Lymphocytic Leukemia (SLL), Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI (Duvelisib, Ibrutinib)

    Terminated
    Has Results
    • Small Lymphocytic Leukemia (SLL)
    • Chronic Lymphocytic Leukemia (CLL)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 15, 2022

    Non-Hodgkins Lymphoma Trial in Fort Myers, Nashville (Cyclophosphamide, Mitoxantrone, Vincristine)

    Completed
    Has Results
    • Non-Hodgkins Lymphoma
    • Fort Myers, Florida
    • +1 more
    Feb 21, 2022

    Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Biospecimen Collection, Follow-Up)

    Recruiting
    • Recurrent Mantle Cell Lymphoma
    • Refractory Mantle Cell Lymphoma
    • Biospecimen Collection
    • Follow-Up
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 5, 2022

    B-cell Non Hodgkin Lymphoma Trial in Augsburg, Cologne, Hamburg (MB-CART2019.1 Dose level 1, MB-CART2019.1 Dose level 2)

    Active, not recruiting
    • B-cell Non Hodgkin Lymphoma
    • MB-CART2019.1 Dose level 1
    • MB-CART2019.1 Dose level 2
    • Augsburg, Bavaria, Germany
    • +2 more
    Jun 13, 2022

    Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Huntsville, Bethesda (Ublituximab,

    Terminated
    • Non-Hodgkins Lymphoma
    • +6 more
    • Huntsville, Alabama
    • +1 more
    May 5, 2022

    Multiple Myeloma, Lymphoma Trial in Omaha (Resistant Starch, Maltodextrin)

    Recruiting
    • Multiple Myeloma
    • Lymphoma
    • Resistant Starch
    • Maltodextrin
    • Omaha, Nebraska
      Nebraska Medicine
    Apr 14, 2022

    Non-Hodgkins Lymphoma Trial in Philadelphia, Houston (hLL2 (epratuzumab))

    Terminated
    • Non-Hodgkins Lymphoma
    • hLL2 (epratuzumab)
    • Philadelphia, Pennsylvania
    • +1 more
    Aug 12, 2021

    Hodgkins Lymphoma Trial in Cologne (Rituximab, BEACOPP escalated)

    Completed
    • Hodgkins Lymphoma
    • Cologne, Germany
      1st Dept. of Medicine, Cologne University Hospital
    Nov 11, 2020

    Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in China (CD19-targeted Chimeric Antigen

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • CD19-targeted Chimeric Antigen Receptor (CAR) T Cells
    • Beijing, Beijing, China
    • +9 more
    Jan 17, 2021